Antares pharma reports q4 earnings per share $0.03

Antares pharma reports fourth quarter and full year 2019 operating and financial results.q4 earnings per share $0.03.q4 revenue $37.8 million versus refinitiv ibes estimate of $32.3 million.q4 earnings per share estimate $0.00 -- refinitiv ibes data.sees fy 2020 revenue $135 million to $155 million.antares pharma - at dec 31, 2019, cash, cash equivalents and short-term investments were $45.7 million compared to $27.9 million at december 31, 2018.
ATRS Ratings Summary
ATRS Quant Ranking